2009 H1N1 Vaccine Providers

This page includes information and resources for North Carolina providers of the 2009 H1N1 Vaccine.

TOPICS:

• Communicating with the Immunization Branch
• Information on recalls and expiration date changes of some lots of H1N1 vaccine
• Questions and Answers from the state (including vaccine recovery information)
• Clinical Information
• Administrative/Billing Information
• Storage and Handling Information
• Resources for Educating Patients on 2009 H1N1 Vaccine

Communicating with the Immunization Branch

• Memos from the Immunization Branch
• Regional Immunization Nurse Consultants (RINs)
• Regional Immunization Program Consultants (RICs)
• Questions about H1N1? Email phpr.sns@dhhs.nc.gov

Weekly Aggregate H1N1 Influenza Vaccine Use Form: All providers must report their usage of H1N1 vaccine to the North Carolina Immunization Branch on a weekly basis. Completed forms must be faxed to the Branch at 1-800-544-3058 or e-mailed to H1N1doses@dhhs.nc.gov by 12 PM (noon) every Monday even if there has been no usage of H1N1 vaccine in the past week. Do not use hash or tic marks. If no doses have been administered put a check in the appropriate field.

• 2009 H1N1 Aggregate Report (PDF Format)
• 2009 H1N1 Aggregate Report (Modifiable Word Format)

Return to Top

Questions and Answers from the State

• Vaccine Returns Flyer from the CDC
• Central H1N1 Vaccine Recovery Program (Memo sent 6/9/10)
  • Letter from the CDC
  • Quick Reference Guide
  • Packing Slip
• Providers who have unexpired H1N1 vaccine in their offices are encouraged to hang on to the vaccine and keep offering it to patients.  If a wave of H1N1 disease were to occur before the 2010-11 seasonal influenza vaccine is available, viable single antigen H1N1 vaccine could be used.   
• N.C. H1N1 Vaccination Issues Q&A for Clinicians and Health Departments, 1/19/10
• Link to archived webcasts of NC H1N1 Operational Briefings at: http://www.epi.state.nc.us/epi/gcdc/H1N1/SERTbriefings.html
• Link to additional information from the state at: http://www.epi.state.nc.us/epi/gcdc/H1N1flu.html

Return to Top

Clinical Information

• CDC Guidance on 2009 H1N1 Vaccine
• CDC Q&A on 2009 H1N1 Nasal Spray Vaccine
• Vaccine Information Statements for 2009 H1N1 - in English and Spanish
  • 2009 H1N1 VISs in many additional languages can be found online at: http://www.cdc.gov/vaccines/pubs/vis/default.htm#h1n1live
• Standing Orders for H1N1 Vaccination - from the Immunization Action Coalition
• Delegation of Immunization Administration to Unlicensed Assistive Personnel
• Mass Vaccination Training Module (for users of the NC Immunization Registry only). This is a Microsoft PowerPoint file.
• 2009 H1N1 Vaccine Package Inserts
• Summary of FDA Approval of 2009 Novel H1N1 Vaccine
• Influenza Vaccination Record Card
• Vaccine Ancillary Supply Kits Overview from CDC
• CDC's Updated Guidance for the Use of CSL's 2009 H1N1 Monovalent Vaccine
• H1N1 Administration with Seasonal Influenza and Other Vaccines
• H1N1 Dose Spacing with Seasonal Influenza and Other Vaccines
• H1N1 Dose Spacing for Children 6 months through 9 years of age
• Differentiate LAIV Seasonal Vaccine and 2009 H1N1
• CSL Provider Package Flyer
• 2009 H1N1 Influenza Vaccine and Ancillary Supply Online Feedback Form

The Vaccine Adverse Event Reporting System is a cooperative program for vaccine safety of the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). VAERS is a post-marketing safety surveillance program, collecting information about adverse events (possible side effects) that occur after the administration of US licensed vaccines.

VAERS collects and analyzes information from reports of adverse events following immunization. Since 1990, VAERS has received over 123,000 reports, most of which describe mild side effects such as fever. Very rarely, people experience serious adverse events following immunization. By monitoring such events, VAERS helps to identify any important new safety concerns and thereby assists in ensuring that the benefits of vaccines continue to be far greater than the risks.

• Vaccine Adverse Event Reporting System

Return to Top